drugset / Trial / NCT02521701
Safety and Efficacity of NFL101 as Tobacco Therapy
NaSingle-groupOpen-labelTreatment
Summary
This Phase I study is to investigate the safety of two dose levels of NFL-101 in smokers.
Timeline
- Start
- 2014-12
- Primary completion
- 2015-12
- Completion
- 2016-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | NFL-101 | Protein / enzyme biologic | 100 ug | — |
| Subject | NFL-101 | Protein / enzyme biologic | 200 ug | — |
Indications
No indication recorded.